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Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296S68received 3 times per week 25 IMJ of 0,2 ml isotonic solution, CS group -
received 3 times per week 25 IMJ of 0,2 ml 10% solution CS. After eutha-
nasia tissues were ﬁxed for 24 hours in 10% neutral buffered formaldehyde.
Kidney, heart and liver were investigated by histological and histochemical
methods. The material was studied by blind method.
Results. At the end of the experiment only 5 males survived in placebo
group, in the CS group - 15males and 10 females. The alive animals were
decapitated. In placebo group ﬁbrocartilage articular surfacewas destroyed
and remodelled. Tide mark was absent. Acid glycosaminoglycanes (GAG)
depletion and collagen network fragmentation have been estimated.
Severe vasculitis in all organs were found. There were severe nephritis,
myocarditis and hepatitis too. In the CS group cartilage was uniform, with
normal thickness and layer differentiation. Cartilage reparation processes
have been estimated as follows - the number of double-nuclear chon-
drocytes increased and accumulated in groups. GAG increased too. Collagen
structure re-established. Tide markwas safe. Dystrophy andmild vasculitis
in heart and liver, severe alteration in kidney were found. There was
signiﬁcant difference between the group results (p<0,05).
Conclusion. Not only cartilage, but organic lesions, such as vasculitis,
nephritis, myocarditis and hepatitis are inﬂuenced after chon-
dromodulators’ treatment of MRL/l mice. These results provide some
insight into the anti-inﬂammatory mechanism of CS action.
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FOLLISTATIN ALLEVIATES SYNOVITIS AND ARTICULAR CARTILAGE
DEGRADATION INDUCED BY CARRAGEENAN IN MICE
K. Tsuji, J. Yamada, K. Miyatake, K. Abula, Y. Matsukura, I. Sekiya,
T. Muneta. Tokyo Med. and Dental Univ., Tokyo, Japan
Purpose: Osteoarthritis (OA), a chronic degenerative joint disorder char-
acterized by articular cartilage destruction and osteophyte formation, is
prevalent in our society as a major cause of disability. Molecular patho-
genesis of OA is not fully understood, it is considered that acute joint
inﬂammation plays signiﬁcant roles in the onset of OA. This idea is sup-
ported by various animal experiments, since articular cartilage degradation
is induced by the intra-articular injection of carrageenan or zymosan.
Previously we showed that intra-articular injection of recombinant human
BMP7 (rhBMP7) inhibited cartilage degradation induced by zymosan
partly through the inhibition of inﬂammatory cytokine expression such as
IL1-beta in the joint. From these data we hypothesized that TGF-beta/BMP
signal maintains joint homeostasis by controlling inﬂammatory status.
Here we report that follistatin, an endogenous inhibitor for Activin which
belongs toTGF-beta/BMP family and works as a proinﬂammatory cytokine,
effectively alleviates synovitis and articular cartilage degradation induced
by the intra-articular injection of carrageenan in mice.
Methods: This study was approved and conducted in accordance with the
guideline of the animal committee of Tokyo Medical and Dental University.
Male C57Bl/6J mice (12weeks old) were purchased from ORIENTAL YEAST
co.,Ltd (Tokyo, Japan). They were housed under a 12-h light-dark cycle and
allowed food andwater ad libitum. Twelvemicewere randomly divided into
two groups (n¼6/group). Mice were anesthetized by the inhalation of 5%
isoﬂurane in oxygen. Under deep anesthesia, a solution of 30mg lamda-
carrageenan (Sigma-Aldrich) in 5mL saline was injected into the left knee
joint through the lateral margin of the patella tendon. Recombinant mouse
follistatin (25ng in 5ml in physiological saline, Sigma-Aldrich) was injected
into the left knee at 30 minutes before carrageenan challenge. Mice were
maintained in cage ad libitum for 3 days after the challenge. Knee jointswere
dissected, ﬁxed in 4% paraformaldehyde, decalciﬁed, embedded, and 5mm
sagittal sections were prepared for histology. Integrity of articular cartilage
and synovium was assessed by Hematoxylin and Eosin staining. To assess
articular cartilage damage, three sections (apart from 150mm respectively)
were stained by Safranin O and 400 mm in width of articular cartilage
between anterior and posterior edge ofmedialmeniscuswas contoured into
3 areas according to the dyeability: Grade I; intact cartilage, Grade II; mildly
denatured cartilagewith reduced safranin O staining, and Grade III; severely
denatured cartilage with no Safranin O staining. Each area was measured
using Zeiss Axio Vision Image Analysis system. Kruskal-Wallis test followed
by Tukey-Kramer methods was used for statistical analysis.
Results: Image analyses indicated that dyeability of articular cartilage by
Safranin O was signiﬁcantly reduced by the single intra-articularinjection of carrageenan at 3 days (Grade I: 21.4%, Grade II: 33.8%, Grade
III: 44.8%), although we did not observe any obvious alteration in the
articular surface structure at this stage. In contrast, the loss of dyeability
after carrageenan injection was signiﬁcantly improved by the pre-
injection of follistatin (Grade I: 26.4%, Grade II: 73.6%, Grade III: 0%,
p<0.05). Hematoxylin and Eosin staining showed that the cellularity of
synovial tissue is greatly increased in carrageenan-injected mice. In
contrast, these inﬂammatory responses were greatly alleviated by the
pre-injection of follistatin.
Conclusions: Carrageenan-induced arthritis is a well-established
experimental model to investigate inﬂammation-mediated articular
cartilage degradation in rodents. Here we report that follistatin effec-
tively inhibits the loss of Safranin O dyeability of articular cartilage
induced by carrageenan. Our data strongly suggest that the Activin signal
pathway is involved in the process of joint inﬂammation and proteo-
glycan loss in the cartilage matrix. We believe that our experimental
system will be of great use for analyzing the molecular events under-
going the onset of OA.
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NEW EVIDENCE LINKING THE IN VIVO IMPLICATION OF 4-
HYDROXYNONENAL IN THE OSTEOARTHRITIS PATHOGENESIS.
Q. Shi, H. Fahmi, J.C. Fernandes, M. Benderdour. Univ. of Montreal,
Montreal, QC, Canada
Purpose: To demonstrate the in vivo involvement of 4-hydroxynonenal
(HNE), a major aldehyde derived from lipid peroxidation of n-6 poly-
unsaturated fatty acids, in the osteoarthritis (OA) pathogenesis.
Methods: Protocol 1 - OA was induced by anterior cruciate ligament
transection of the right knee in crossbred dogs. There were two experi-
mental groups (n¼4 dogs/group): placebo and carnosine (an HNE-trapping
drug, 50 mg/kg/day) given orally for 8 weeks Protocol 2 - Vehicle or
pathophysiological dose of HNE (100 mM) were injected weekly into the
right knee joint of crossbred dogs (n¼4 dogs/group) for the entire duration
of the study (16 weeks). We conducted macroscopic and histomorpho-
logical analyses of cartilage of the femoral condyles and/or tibial plateaus.
We also conducted immunohistochemical analyses in cartilage explants
for the following antigens: HNE, agrecannase-2, and matrix metal-
loproteinase -13 (MMP-13).
Results: In the protocol 1, treatment with carnosine reduced the severity
and histopathological score of OA cartilage lesions as well as the levels of
HNE, MMP-13 and agrecannase-2 in cartilage explants. In the protocol 2,
the intraarticular injection of HNE induced cartilage lesions on the tibial
plateaus and femoral condyles with prominent osteophytes on lateral
condyles. The expression of both MMP-13 and agrecannase-2 increased in
cartilage explants from HNE-treated dogs.
Conclusions: This is the ﬁrst in vivo study to demonstrate the patho-
physiological role of HNE in OA. The fact that carnosine abolishes HNE
production and a number of factors known to be involved in OA patho-
genesis renders it a clinically valuable agent in the prevention of this
disease.
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A COLLAGEN-PLATELET COMPOSITE TO STIMULATE HEALING AFTER
ACL SURGERY ALSO MINIMIZES CARTILAGE DAMAGE IN THE ACL
INJURED KNEE
B.C. Fleming 1, J.T. Machan 1, M.R. Shalvoy 1, M.M. Murray 2. 1Alpert Med.
Sch. of Brown Univ., Providence, RI; 2Childrens Hosp. Boston, Boston, MA
Purpose: ACL injury is a risk factor for early post-traumatic osteoarthritis
(PTOA), and the gold standard of treatment, ACL reconstruction, does not
reduce this risk. The mechanism of PTOA in the ACL injured joint is likely
due both to the initial inﬂammation and ongoing subtle mechanical
instability. Recently, intra-articular implantation of a collagen-platelet
composite (CPC) during surgery in animal models has been shown to
improve healing following bio-enhanced ACL repair or ACL reconstruction
procedures, though the impact of the CPC on articular cartilage remains
unknown. We hypothesize that cartilage integrity following bio-enhanced
Abstracts / Osteoarthritis and Cartilage 20 (2012) S54–S296 S69ACL repair (BE-repair) and bio-enhanced ACL reconstruction (BE-ACLR) is
improved when compared to traditional ACL reconstruction (ACLR) or ACL
transection with no treatment (ACLT).
Methods: With IACUC approval, 31 adolescent minipigs underwent
surgical ACL transection in one knee followed by BE-repair (n¼8), BE-ACLR
(n¼8), ACLR (n¼8), and no treatment (ACLT; n¼7). After 12 months of
healing, the articulating surfaces of the surgically treated and contralateral
ACL intact knees were macroscopically graded following application of
India ink using a ﬁve point scale (0¼no changes; 1¼intact surface with
color changes; 2¼surface ﬁbrillation; 3¼exposed bone10%). The surface
areas of all lesions were determined using calipers and an elliptical ﬁt. A
mixed linear model was used to make comparisons between treatments
(BE-repair, BE-ACLR, ACLR, and ACLT) and compartments (medial femoral
condyle, lateral femoral condyle, medial tibial plateau, and lateral tibial
plateau). Similar analyses were performed to compare the lesion areas
within each compartment. All statistical analyses were done on the
difference between the surgical and contralateral ACL-intact knee within
each animal.
Results:We found signiﬁcantmean differences in cartilage scores between
treatments (p¼0.05) and compartments (p<0.01). The mean difference 
conﬁdence interval for BE-repair, BE-ACLR, ACLR and ACLT (pooled across
compartments) were 0.240.193, 0.160.241, 0.480.181, and 0.660.392,
respectively. Only the knees treated with BE-ACLR did not have increased
chondral injury on the surgical side. For the lesion area measurements, the
treatment effect was statistically signiﬁcant in the medial femoral condyle
(p¼0.012). The mean difference  conﬁdence interval between the
surgical and contralateral ACL-intact knees for BE-repair, BE-ACLR, ACLR
and ACLT were 517.8mm2, -1923.1mm2, 4031.9mm2, and
5751.5mm2, respectively. Both the BE-repair and BE-ACLR procedures
resulted in mean differences between the operative and non-operative
side that were not signiﬁcantly different from zero. It should also be noted
that there were no lesions in either the surgical or contralateral ACL intact
knee in the lateral femoral condyle or medial tibial plateau for any animal
undergoing BE-repair.
Conclusions: ACL transection and ACL reconstruction both resulted in
increased chondral damage of the knee at one year after surgery as
noted in humans. In contrast, treatment of the ACL transection with
either bio-enhanced repair with CPC or ACL reconstruction
augmented with CPC prevented this increased chondral damage.
These data suggest that the intra-articular application of CPC may be
chondroprotective.
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CHRONICITY PRODUCES DIFFERENTIAL ALTERATIONS IN PAIN
BEHAVIORS IN MURINE OSTEOARTHRITIS
H.E. Krug 1,2, C. Dorman 2, S.P. Frizelle 2, M.L. Mahowald 1,2. 1Univ. of
Minnesota, Minneapolis, MN; 2Minneapolis VA Hlth.Care System,
Minneapolis, MN
Purpose: Osteoarthritis pain is a growing problem due to an expanding
elderly population and lack of safe and effective therapies. Understanding
the origins and pathogenesis of chronic arthritis pain is important for
developing effective therapies. Osteoarthritis pain does not correlate well
with radiographic severity, and loss of function in patients with osteoar-
thritis may result from pain, from altered biomechanics or from toxicity of
analgesics. In order to better understand the relationship between osteo-
arthritis, pain, and function, wemeasured different types of pain behaviors
in mice with osteoarthritis as a function of age, duration of arthritis and in
response to different analgesic treatments.
Methods: Collagenase (10 IU) in 10 ml was given by intra-articular (IA)
injection into the left knee of 4-week-old C57Bl6 male mice. This produced
osteoarthritis that was identiﬁable histologically after 4 weeks. Arthritic
mice were compared to uninjected naïve mice of the same age at 4 weeks
and 6weeks after collagenase injection and to arthriticmice treatedwith IA
analgesics. Analgesics testedwere IAmorphine sulfate (0.7mg/kg in 5 ml) or
IA Botulinum toxin type A (BoNT/A) (0.02 IU given 3 d before testing). Pain
behavior measures included evoked pain response to repetitive ﬁrm
palpation of the knee for 1 minute, voluntary, spontaneous nocturnal
wheel-running, mechanical withdrawal thresholds by Von Frey ﬁlamenttesting and digitized video gait analysis using DigiGaitTM (Mouse Speciﬁcs,
Inc, Quincy,MA). The nonarthritic kneewas the internal nonpainful control.
Results: At both 4 and 6 weeks after collagenase injection, evoked pain
responses in arthritic knees were increased, but this response was 65%
greater at 4 weeks than at 6 weeks. Arthritis caused an increased swing/
stride ratio measured by gait analysis and increased mechanical allodynia
in the arthritic limb by Von Frey ﬁlament testing at both 4 and 6 weeks.
Von Frey testing in the normal right limb revealed allodynia at 4 weeks but
an increased pain threshold at 6 weeks. Spontaneous nocturnal wheel-
running was reduced in both the 4 and 6 week arthritic groups, as well as
in 6 week naïvemice. Both BoNT/A andMorphinewere effective analgesics
at 4 and 6 weeks as measured by evoked pain but did not normalize gait
function at either time point. Only morphine normalized the threshold for
mechanical allodynia to Von Frey ﬁlament testing at 4 weeks, but IA BoNT/
A was more effective at 6 weeks.
Conclusions: IA injection of collagenase in mouse knees produces arthritis
pain that can be measured by various methods at 4 weeks and persists to 6
weeks. Both opioids and BoNT/A given IA are effective analgesics when
pain is measured by evoked pain behavior. Changes in functional measures
such as gait analysis do reﬂect the development of arthritis pain but are not
clearly normalized by analgesia and may be due not only to pain but to
biomechanical changes in the joints. Chronic osteoarthritis pain produces
mechanical allodynia, one indication of peripheral sensitization.
Mechanical allodynia may be decreased by opioids if arthritis pain is not
longstanding but IA BoNT/A may be more effective for sensitization due to
arthritis that is more chronic. More work needs to be done to determine
which pain behaviors best measure chronic pain in murine arthritis and
are sensitive for detecting analgesia in order to use preclinical models for
testing potential new analgesics.
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LDL RECEPTOR DEFICIENCY RESULTS IN INCREASED OSTEOPHYTE
FORMATION DURING EXPERIMENTAL OSTEOARTHRITIS BOTH UNDER
LOW AND HIGH CHOLESTEROL CONDITIONS
W. de Munter, B. Walgreen, M.M. Helsen, A.W. Sloetjes, W.B. van den
Berg, P.L. van Lent. Radboud Univ. Nijmegen Med. Ctr., Nijmegen,
NETHERLANDS
Purpose: Synovial macrophages have previously shown to be involved in
joint destruction during experimental collagenase-induced osteoarthritis
(OA). The low density lipoprotein (LDL) receptor expressed by synovial
macrophages is involved in transport of cholesterol, carrying lipoprotein
particles into cells, thereby regulating cholesterol homeostasis. In the
present study we investigated whether the LDL receptor is involved in
joint destruction during experimental osteoarthritis both under normal
and high cholesterol conditions.
Material and Methods: LDL receptor deﬁcient (LDLR-/-) mice and their
wild type (WT) controls received either a high cholesterol or control
diet for 120 days. Experimental osteoarthritis was induced by injection
of collagenase into the mice's knee joints on day 84 and 86. Parafﬁn
sections of total knee joints were stained with safranin-o or haema-
toxylin-eosin to determine OA development. Synovial activation
(thickening of the lining layer) was measured using an arbitrary scale
from 0 to 3. Cartilage destruction was determined in four cartilage
surfaces (lateral and medial femur and tibia) using the OA score (with
a maximum of 30 per knee joint) developed by Pritzker et al (2006) and
adapted by our lab for mice. Size of osteophyte formation was
measured on the edges of the femur/tibia area using image analysis.
Results are depicted as mean  SD.
Results: On day 36 after induction of collagenase-induced OA, WT
mice which received a normal diet (n¼10) developed moderate
synovial activation (1.4  0.6), cartilage destruction (6.1  2.6) and
osteophyte formation (32.4 mm2  25.4). In LDLR-/- mice (n¼10) no
signiﬁcant differences were found on synovial activation or cartilage
destruction when compared to WT controls. In contrast, mean
osteophyte formation was tremendously increased by 345 % sug-
gesting that the absence of the LDL receptor induces osteophyte
formation in the OA knee joint.
